<DOC>
	<DOC>NCT01611311</DOC>
	<brief_summary>The primary objective of the current study is to investigate the safety and tolerability of BI 409306 in healthy young and elderly male and female volunteers following oral administration of repeated rising doses, given once daily over 14 days to young healthy genotyped and elderly healthy male/female volunteers.</brief_summary>
	<brief_title>Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: 1. Healthy male/female subjects Exclusion criteria: 1. Any relevant deviation from healthy conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>